av/mevis-medical-solutions-ag--big.svg

DE:MEVIS

MeVis Medical Solutions AG

  • Stock

Last Close

25.20

22/11 14:08

Market Cap

46.23M

Beta: -

Volume Today

102

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
average inventory
90.50K
-
average payables
990K
-
707.50K
28.54%
566K
20%
416K
26.50%
307.50K
26.08%
173.28K
43.65%
51.66K
70.19%
166.25K
221.85%
216.16K
30.02%
134.65K
37.71%
average receivables
2.22M
-
book value per share
15.35
-
17.57
14.46%
18.84
7.19%
17.86
5.17%
17.61
1.39%
9.79
44.40%
9.79
0%
9.79
0%
9.79
0%
capex per share
-1.08
-
-0.91
15.95%
-0.06
92.85%
-0.12
87.44%
-0.11
5.88%
-0.11
2.44%
-0.06
49.46%
-0.03
50.41%
-0.07
161.69%
capex to depreciation
-0.86
-
-0.92
6.52%
-0.06
93.50%
-0.18
203.39%
-0.23
26.01%
-0.79
246.37%
-0.61
22.75%
-0.41
33.81%
-1.43
252.99%
-0.83
41.85%
capex to operating cash flow
-0.25
-
-0.32
30.19%
-0.02
94.54%
-0.03
71.19%
-0.04
24.85%
-0.03
17.70%
-0.04
14.46%
-0.01
84.30%
-0.03
391.94%
-0.01
50.30%
capex to revenue
-0.13
-
-0.12
6.15%
-0.01
93.92%
-0.01
64.56%
-0.01
4.13%
-0.01
9.54%
-0.01
46.68%
-0.00
47.60%
-0.01
126.15%
-0.00
35.20%
cash per share
8.20
-
10.19
24.25%
14.34
40.69%
16.34
13.97%
1.91
88.31%
1.43
25.22%
2.17
52.05%
4.19
92.76%
5.12
22.30%
days of inventory on hand
days payables outstanding
446.76
-
333.34
25.39%
329.81
1.06%
201.25
38.98%
258.73
28.56%
8.44
96.74%
54.06
540.58%
200.32
270.58%
94.15
53.00%
62.91
33.18%
days sales outstanding
debt to assets
0.01
-
0.01
16.35%
0.10
1,307.26%
0.19
83.34%
0.04
77.92%
debt to equity
0.01
-
0.01
18.67%
0.14
1,403.78%
0.29
104.95%
0.05
82.47%
dividend yield
0.00
-
0.15
-
0.03
80.16%
0.03
9.08%
0.10
254.18%
0.07
24.03%
earnings yield
0.10
-
0.12
14.13%
0.16
31.63%
0.08
49.60%
0.12
45.86%
0.15
29.17%
0.10
33.77%
0.08
22.26%
0.13
63.33%
enterprise value
25.70M
-
22.20M
13.60%
22.10M
0.48%
50.81M
129.97%
60.39M
18.84%
51.64M
14.49%
53.92M
4.43%
51.71M
4.10%
52.92M
2.34%
-7.74M
114.63%
enterprise value over ebitda
4.20
-
3.24
22.79%
3.10
4.30%
6.00
93.69%
7.17
19.47%
6.13
14.54%
9.03
47.22%
9.62
6.58%
6.64
31.01%
-1.50
122.56%
ev to operating cash flow
3.43
-
4.60
33.83%
3.36
26.94%
6.94
106.64%
10.94
57.65%
7.89
27.87%
18.66
136.50%
5.66
69.65%
10.90
92.39%
-1.32
112.14%
ev to sales
1.76
-
1.70
3.53%
1.38
18.64%
2.74
98.64%
3.60
31.48%
2.86
20.71%
3.15
10.17%
3.19
1.32%
2.82
11.55%
-0.45
115.83%
free cash flow per share
3.27
-
1.90
41.87%
3.61
90.12%
3.90
8.09%
2.92
25.20%
3.48
19.36%
1.53
56.05%
4.99
225.78%
2.60
47.97%
free cash flow yield
0.16
-
0.10
34.23%
0.15
43.42%
0.10
33.67%
0.09
14.46%
0.12
36.99%
0.05
58.81%
0.15
217.78%
0.08
50.41%
graham net net
3.60
-
5.55
54.37%
7.74
39.25%
7.24
6.46%
-1.58
121.89%
-1.92
21.18%
-3.30
72.07%
-1.15
65.29%
-2.23
94.34%
graham number
27.17
-
29.20
7.45%
39.93
36.76%
35.24
11.75%
39.52
12.15%
31.26
20.89%
26.28
15.93%
23.46
10.73%
30.71
30.90%
income quality
1.86
-
1.24
33.18%
1.47
18.55%
0.92
37.52%
0.82
10.34%
0.81
1.68%
0.51
37.52%
2.01
296.48%
0.62
68.95%
1.19
90.81%
intangibles to total assets
0.48
-
0.41
14.22%
0.30
25.52%
0.24
21.47%
0.29
21.15%
0.00
99.73%
0.00
88.63%
0.00
85.92%
0.00
59.51%
0
100%
interest coverage
27.20
-
62.74
130.65%
67.73
7.95%
103.40
52.67%
88.08
14.82%
829.82
842.13%
495.07
40.34%
485.12
2.01%
2.05K
321.71%
118.55
94.21%
interest debt per share
0.26
-
0.20
23.67%
2.69
1,240.58%
5.19
93.27%
0.93
82.05%
0.01
99.42%
0.01
19.19%
0.01
7.73%
0.00
64.40%
inventory turnover
invested capital
0.01
-
0.01
18.67%
0.14
1,403.78%
0.29
104.95%
0.05
82.47%
market cap
35.28M
-
31.18M
11.62%
42.97M
37.81%
71.18M
65.63%
62.24M
12.55%
54.24M
12.87%
57.88M
6.71%
59.33M
2.52%
62.24M
4.91%
net current asset value
9.58M
-
12.70M
32.65%
16.90M
33.03%
16.85M
0.32%
795K
95.28%
1.03M
29.19%
1.09M
6.32%
1.17M
6.84%
1.13M
3.43%
1.14M
1.43%
net debt to ebitda
-1.57
-
-1.31
16.28%
-2.93
123.47%
-2.41
17.84%
-0.22
90.83%
-0.31
39.88%
-0.66
114.35%
-1.42
114.23%
-1.17
17.56%
-1.50
28.08%
net income per share
2.14
-
2.16
0.87%
3.76
74.49%
3.09
17.87%
3.94
27.55%
4.43
12.55%
3.13
29.33%
2.50
20.31%
4.28
71.35%
operating cash flow per share
4.34
-
2.80
35.44%
3.68
31.04%
4.02
9.49%
3.03
24.62%
3.60
18.54%
1.59
55.84%
5.02
215.97%
2.67
46.80%
payables turnover
0.82
-
1.09
34.03%
1.11
1.07%
1.81
63.88%
1.41
22.22%
43.25
2,965.99%
6.75
84.39%
1.82
73.01%
3.88
112.78%
5.80
49.65%
receivables turnover
research and ddevelopement to revenue
return on tangible assets
0.20
-
0.16
19.73%
0.21
29.53%
0.15
29.18%
0.26
74.53%
0.34
28.56%
0.21
39.21%
0.17
19.57%
0.25
51.21%
0.18
29.75%
revenue per share
8.49
-
7.60
10.44%
8.94
17.67%
10.19
13.90%
9.21
9.61%
9.93
7.85%
9.41
5.21%
8.91
5.35%
10.31
15.71%
roe
0.14
-
0.12
11.88%
0.20
62.79%
0.17
13.40%
0.22
29.35%
0.45
102.41%
0.32
29.33%
0.26
20.31%
0.44
71.35%
0.28
36.84%
roic
0.15
-
0.10
34.40%
0.16
65.95%
0.15
5.62%
0.20
31.72%
0.45
130.79%
0.32
29.27%
0.29
9.84%
0.44
51.23%
0.28
36.34%
sales general and administrative to revenue
0.03
-
0.03
5.18%
0.05
94.69%
0.01
74.03%
0.01
28.23%
0.03
223.65%
0.04
31.68%
0.05
12.76%
0.02
47.44%
0.03
7.70%
shareholders equity per share
15.35
-
17.57
14.46%
18.84
7.19%
17.86
5.17%
17.61
1.39%
9.79
44.40%
9.79
0%
9.79
0%
9.79
0%
stock based compensation to revenue
tangible asset value
10.08M
-
14.65M
45.30%
19.88M
35.67%
20.79M
4.60%
20.94M
0.74%
17.81M
14.97%
17.82M
0.09%
17.83M
0.01%
17.83M
0.00%
17.83M
0.00%
tangible book value per share
5.85
-
8.50
45.30%
11.10
30.51%
11.42
2.91%
11.51
0.74%
9.78
14.97%
9.79
0.09%
9.79
0.01%
9.79
0.00%
working capital
11.58M
-
15.31M
32.13%
17.05M
11.39%
17.15M
0.57%
1.12M
93.46%
3.56M
217.54%
3.58M
0.52%
4.22M
17.81%
4.83M
14.48%
4.52M
6.38%

All numbers in (except ratios and percentages)